Takeda Draws On Nycomed Buy To Form Global Vaccine Unit
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical plans to go global next year with an expanded vaccines division, drawing on its acquisition earlier this year of Nycomed and its presence in Europe and emerging markets.